Antibody Drug Conjugates in Bladder Cancer: Current Milestones and Future Perspectives.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1167, doi. 10.1007/s11864-023-01114-y
- By:
- Publication type:
- Article
Works matching IS 15272729 AND DT 2023 AND VI 24 AND IP 9
Results: 11
1
2
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1274, doi. 10.1007/s11864-023-01120-0
- By:
- Publication type:
- Article
3
The Evolving Treatment Landscape of Merkel Cell Carcinoma.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1231, doi. 10.1007/s11864-023-01118-8
- By:
- Publication type:
- Article
4
Management of Thromboembolic Disease in Patients with Primary and Metastatic Brain Tumors.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1293, doi. 10.1007/s11864-023-01116-w
- By:
- Publication type:
- Article
5
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1213, doi. 10.1007/s11864-023-01113-z
- By:
- Publication type:
- Article
6
Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1259, doi. 10.1007/s11864-023-01112-0
- By:
- Publication type:
- Article
7
CDK4/6 Inhibition in the Metastatic Setting: Where Are We Headed?
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1103, doi. 10.1007/s11864-023-01109-9
- By:
- Publication type:
- Article
8
Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1120, doi. 10.1007/s11864-023-01108-w
- By:
- Publication type:
- Article
9
Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1199, doi. 10.1007/s11864-023-01107-x
- By:
- Publication type:
- Article
10
Targeting HIF-2 Alpha in Renal Cell Carcinoma.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1183, doi. 10.1007/s11864-023-01106-y
- By:
- Publication type:
- Article
11
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 9, p. 1138, doi. 10.1007/s11864-023-01101-3
- By:
- Publication type:
- Article